/compare — side-by-sideLOADING
Valuation, growth, margins and forensic scores side-by-side — computed from each company's own SEC filings and last EOD close. No estimates, no fluff.
| Metric | AIMAIM ImmunoTech Inc. |
|---|---|
| Last close | $0.22 |
| Change % | -14.97% |
| Market cap | $7M |
| P/E | — |
| Revenue | $88000 |
| Rev growth (YoY) | -48.2% |
| Net income | $-13958000 |
| Net margin | -15861.4% |
| EPS (diluted) | $-8.62 |
| Piotroski F-ScoreUNVALIDATED | 2 |
| Altman Z-ScoreUNVALIDATED | -113.72 |
| Beneish M-ScoreUNVALIDATED | — |
| Next earnings | 05-13 → 05-23 |
Fundamentals from XBRL company facts (as filed); market cap & P/E use last EOD close. Green = best in the row among the compared names. Educational only — not investment advice.